{"id":129685,"date":"2021-09-24T00:00:00","date_gmt":"2023-03-15T11:18:45","guid":{"rendered":"https:\/\/www.mdbriefcase.com\/course\/examining-the-cardiorenal-benefits-of-sglt2-inhibitors-for-people-with-type-2-diabetes\/"},"modified":"2023-05-02T08:55:53","modified_gmt":"2023-05-02T12:55:53","slug":"examining-the-cardiorenal-benefits-of-sglt2-inhibitors-for-people-with-type-2-diabetes","status":"publish","type":"eb_course","link":"https:\/\/www.mdbriefcase.com\/fr\/courses\/examining-the-cardiorenal-benefits-of-sglt2-inhibitors-for-people-with-type-2-diabetes\/","title":{"rendered":"Examining the cardiorenal benefits of SGLT2 inhibitors for people with type 2 diabetes"},"content":{"rendered":"<p>In recent landmark trials, certain SGLT2 inhibitors have demonstrated cardiovascular and renal benefits in patients with type 2 diabetes.\n<\/p>\n<p>This video helps clinicians navigate the most recent clinical evidence for SGLT2 inhibitors and reviews the updated recommendations from the Diabetes Canada guidelines. The goal is to help clinicians apply the cardiorenal evidence to primary care practice and increase their confidence in identifying patients who would benefit from SGLT2i and initiating SGLT2i in those patients.\n<\/p>\n<hr>\n<p>This program has received an educational grant or in-kind support from Astra Zeneca.<\/p>","protected":false},"featured_media":441676,"comment_status":"closed","ping_status":"closed","template":"","eb_course_cat":[],"class_list":["post-129685","eb_course","type-eb_course","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Examining the cardiorenal benefits of SGLT2 inhibitors for people with type 2 diabetes - MDBriefCase<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.mdbriefcase.com\/fr\/cours\/examining-the-cardiorenal-benefits-of-sglt2-inhibitors-for-people-with-type-2-diabetes\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Examining the cardiorenal benefits of SGLT2 inhibitors for people with type 2 diabetes - MDBriefCase\" \/>\n<meta property=\"og:description\" content=\"In recent landmark trials, certain SGLT2 inhibitors have demonstrated cardiovascular and renal benefits in patients with type 2 diabetes. This video helps clinicians navigate the most recent clinical evidence for SGLT2 inhibitors and reviews the updated recommendations from the Diabetes Canada guidelines. The goal is to help clinicians apply the cardiorenal evidence to primary care [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.mdbriefcase.com\/fr\/cours\/examining-the-cardiorenal-benefits-of-sglt2-inhibitors-for-people-with-type-2-diabetes\/\" \/>\n<meta property=\"og:site_name\" content=\"MDBriefCase\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-02T12:55:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2021\/09\/SGLT-CVD-EB-LP-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"338\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/examining-the-cardiorenal-benefits-of-sglt2-inhibitors-for-people-with-type-2-diabetes\/\",\"url\":\"https:\/\/www.mdbriefcase.com\/courses\/examining-the-cardiorenal-benefits-of-sglt2-inhibitors-for-people-with-type-2-diabetes\/\",\"name\":\"Examining the cardiorenal benefits of SGLT2 inhibitors for people with type 2 diabetes - MDBriefCase\",\"isPartOf\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/examining-the-cardiorenal-benefits-of-sglt2-inhibitors-for-people-with-type-2-diabetes\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/examining-the-cardiorenal-benefits-of-sglt2-inhibitors-for-people-with-type-2-diabetes\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2021\/09\/SGLT-CVD-EB-LP-1.jpg\",\"datePublished\":\"2023-03-15T11:18:45+00:00\",\"dateModified\":\"2023-05-02T12:55:53+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/examining-the-cardiorenal-benefits-of-sglt2-inhibitors-for-people-with-type-2-diabetes\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.mdbriefcase.com\/courses\/examining-the-cardiorenal-benefits-of-sglt2-inhibitors-for-people-with-type-2-diabetes\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/examining-the-cardiorenal-benefits-of-sglt2-inhibitors-for-people-with-type-2-diabetes\/#primaryimage\",\"url\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2021\/09\/SGLT-CVD-EB-LP-1.jpg\",\"contentUrl\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2021\/09\/SGLT-CVD-EB-LP-1.jpg\",\"width\":600,\"height\":338},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/examining-the-cardiorenal-benefits-of-sglt2-inhibitors-for-people-with-type-2-diabetes\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.mdbriefcase.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Course\",\"item\":\"https:\/\/www.mdbriefcase.com\/courses\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Examining the cardiorenal benefits of SGLT2 inhibitors for people with type 2 diabetes\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.mdbriefcase.com\/#website\",\"url\":\"https:\/\/www.mdbriefcase.com\/\",\"name\":\"MDBriefCase\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.mdbriefcase.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.mdbriefcase.com\/#organization\",\"name\":\"MDBriefCase\",\"url\":\"https:\/\/www.mdbriefcase.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp\",\"contentUrl\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp\",\"width\":190,\"height\":36,\"caption\":\"MDBriefCase\"},\"image\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Examining the cardiorenal benefits of SGLT2 inhibitors for people with type 2 diabetes - MDBriefCase","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.mdbriefcase.com\/fr\/cours\/examining-the-cardiorenal-benefits-of-sglt2-inhibitors-for-people-with-type-2-diabetes\/","og_locale":"fr_CA","og_type":"article","og_title":"Examining the cardiorenal benefits of SGLT2 inhibitors for people with type 2 diabetes - MDBriefCase","og_description":"In recent landmark trials, certain SGLT2 inhibitors have demonstrated cardiovascular and renal benefits in patients with type 2 diabetes. This video helps clinicians navigate the most recent clinical evidence for SGLT2 inhibitors and reviews the updated recommendations from the Diabetes Canada guidelines. The goal is to help clinicians apply the cardiorenal evidence to primary care [&hellip;]","og_url":"https:\/\/www.mdbriefcase.com\/fr\/cours\/examining-the-cardiorenal-benefits-of-sglt2-inhibitors-for-people-with-type-2-diabetes\/","og_site_name":"MDBriefCase","article_modified_time":"2023-05-02T12:55:53+00:00","og_image":[{"width":600,"height":338,"url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2021\/09\/SGLT-CVD-EB-LP-1.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.mdbriefcase.com\/courses\/examining-the-cardiorenal-benefits-of-sglt2-inhibitors-for-people-with-type-2-diabetes\/","url":"https:\/\/www.mdbriefcase.com\/courses\/examining-the-cardiorenal-benefits-of-sglt2-inhibitors-for-people-with-type-2-diabetes\/","name":"Examining the cardiorenal benefits of SGLT2 inhibitors for people with type 2 diabetes - MDBriefCase","isPartOf":{"@id":"https:\/\/www.mdbriefcase.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.mdbriefcase.com\/courses\/examining-the-cardiorenal-benefits-of-sglt2-inhibitors-for-people-with-type-2-diabetes\/#primaryimage"},"image":{"@id":"https:\/\/www.mdbriefcase.com\/courses\/examining-the-cardiorenal-benefits-of-sglt2-inhibitors-for-people-with-type-2-diabetes\/#primaryimage"},"thumbnailUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2021\/09\/SGLT-CVD-EB-LP-1.jpg","datePublished":"2023-03-15T11:18:45+00:00","dateModified":"2023-05-02T12:55:53+00:00","breadcrumb":{"@id":"https:\/\/www.mdbriefcase.com\/courses\/examining-the-cardiorenal-benefits-of-sglt2-inhibitors-for-people-with-type-2-diabetes\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.mdbriefcase.com\/courses\/examining-the-cardiorenal-benefits-of-sglt2-inhibitors-for-people-with-type-2-diabetes\/"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.mdbriefcase.com\/courses\/examining-the-cardiorenal-benefits-of-sglt2-inhibitors-for-people-with-type-2-diabetes\/#primaryimage","url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2021\/09\/SGLT-CVD-EB-LP-1.jpg","contentUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2021\/09\/SGLT-CVD-EB-LP-1.jpg","width":600,"height":338},{"@type":"BreadcrumbList","@id":"https:\/\/www.mdbriefcase.com\/courses\/examining-the-cardiorenal-benefits-of-sglt2-inhibitors-for-people-with-type-2-diabetes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.mdbriefcase.com\/"},{"@type":"ListItem","position":2,"name":"Course","item":"https:\/\/www.mdbriefcase.com\/courses\/"},{"@type":"ListItem","position":3,"name":"Examining the cardiorenal benefits of SGLT2 inhibitors for people with type 2 diabetes"}]},{"@type":"WebSite","@id":"https:\/\/www.mdbriefcase.com\/#website","url":"https:\/\/www.mdbriefcase.com\/","name":"MDBriefCase","description":"","publisher":{"@id":"https:\/\/www.mdbriefcase.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.mdbriefcase.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.mdbriefcase.com\/#organization","name":"MDBriefCase","url":"https:\/\/www.mdbriefcase.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp","contentUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp","width":190,"height":36,"caption":"MDBriefCase"},"image":{"@id":"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course\/129685","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course"}],"about":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/types\/eb_course"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/comments?post=129685"}],"version-history":[{"count":0,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course\/129685\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/media\/441676"}],"wp:attachment":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/media?parent=129685"}],"wp:term":[{"taxonomy":"eb_course_cat","embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course_cat?post=129685"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}